Journals / Üroonkoloji Bülteni / 2016 / Cilt: 15 - Sayı: 2

Additional Surgical Procedures During Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients with Nonseminomatous Testicular Tumor

Seminom Dışı Testis Tümörlü Hastalarda Postkemoterapötik Retroperitoneal Lenf Nodu Diseksiyonu Sırasında Ek Cerrahi Girişimler

Pages
44–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, major vascular procedures such as aort or vena cava excision and replacement may be required are need in more complex cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Retroperitoneal lymph node dissection (RLND) is frequently performed in non-seminomatous testicular tumor (TT) patients, especially in cases who have radiological residual mass despite normal tumor markers after chemotherapy (CT).
📊
Key Findings & Data:Materials and Methods: Between January 2000-July 2015, 63 metastatic non-seminomatous TT patients undergoing RLND due to residual mass after CT at our clinic were evaluated for additional surgical procedures during RLND.
💡
Conclusion & Impact:However, major vascular procedures such as aort or vena cava excision and replacement may be required are need in more complex cases.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Retroperitoneal lymph node dissection (RLND) is frequently performed in non-seminomatous testicular tumor (TT) patients, especially in cases who have radiological residual mass despite normal tumor markers after chemotherapy (CT). On the other hand, additional surgical procedures may be required in post-CT patients during RLND due to high probability of severely invasion of residual mass to surrounding organs and major vascular structures. In this study, we aimed to evaluate the additional surgical procedures and complications during RLND. Materials and Methods: Between January 2000-July 2015, 63 metastatic non-seminomatous TT patients undergoing RLND due to residual mass after CT at our clinic were evaluated for additional surgical procedures during RLND. Age at surgery, localization of TT, clinic stage before CT, number of CT cycles, retroperitoneal mass size, duration of hospitalization, history of additional surgical procedures during surgery and RLND's pathology of patients were evaluated. Clinic stage before CT was assessed according to 2009 tumor, node, metastasis staging system. For all patients, RLND was performed as right or left template according to localization of tumor. Results: The mean age of patients was 32.6±8.6 years. Additional surgical procedures were performed in 10 (15.9%) patients. In five patients, ipsilateral nephrectomy, in two patients vena cava excision and repair, in one patient aorta excision and replacement, in one patient ureteral segment excision and anastomosis and in one patient transverse colon resection were performed. On multivariate analysis, >5 cm mass size was determined to increase likelihood of significant additional surgical procedure (p=0.001, OR: 2.1, 95% CI: 1.088-4.202). Conclusion: For complete resection, the most common additional surgical procedure during surgery is nephrectomy following CT in RLND patients. However, major vascular procedures such as aort or vena cava excision and replacement may be required are need in more complex cases.

Özet

Amaç: Retroperitoneal lenf nodu diseksiyonu (RLND) seminom dışı testis tümörüne (TT) sahip hastalarda özellikle kemoterapi (KT) sonrası tümör belirteçlerinin normal olmasına rağmen radyolojik rezidü kitlelerin olduğu olgularda sıklıkla uygulanmaktadır. Öte yandan, rezidü kitlelerin çevre organlara ve ana vasküler yapılara ciddi invazyon olasılığı yüksek olduğundan, postkemoterapötik RLND sırasında ek cerrahi girişimlere ihtiyaç duyulabilir. Bu çalışmada RLND sırasında uygulanılan ek cerrahi girişimler ve bu cerrahi sırasında gelişen komplikasyonları değerlendirmeyi amaçladık. Gereç ve Yöntem: Kliniğimizde Ocak 2000-Temmuz 2015 tarihleri arasında takipleri olan KT sonrası rezidüel kitle nedeniyle açık RLND yapılan 63 metastatik seminom dışı TT hasta RLND sırasında uygulanılan ek cerrahi girişimler açısından incelendi. Olguların cerrahi sırasındaki yaşı, TT lokalizasyonu, KT öncesi klinik evresi, KT kürü sayısı, retroperitoneal kitle boyutu, hastanede kalış süresi, cerrahi sırasında yapılan ek girişim öyküleri ve RLND patolojileri değerlendirildi. KT öncesi klinik tümör evresi 2009 tümör, nod, metastaz evreleme sistemine göre değerlendirildi. Tüm hastalarda RLND, kitlenin lokalizasyonuna göre sağ veya sol template şeklinde yapıldı. Bulgular: Hastaların ortalama yaşı 32,6±8,6 yıl idi. On (%15,9) olguda RLND sırasında ek cerrahi uygulandığı belirlendi. Beş hastada nefrektomi, iki hastada vena kava eksizyonu ve onarımı, bir hastada aort eksizyonu ve replasmanı, bir hastada segmental üreter eksizyonu ve bir hastada ise transvers kolon rezeksiyonu yapıldı. Çok değişkenli analizde, sadece kitle boyutunun 5 cm'den büyük olmasının ek cerrahi girişim olasılığını artırdığı belirlendi (p=0,001, OR: 2,1, %95 CI: 1,088-4,202). Sonuç: KT sonrası RLND yapılan olgularda cerrahi sırasında kitlelerin tam çıkarılabilmesi için en sık uygulanılan ek cerrahi girişim nefrektomidir. Ancak daha kompleks olgularda aort ve vena kava gibi büyük damarların eksizyon ve replasmanı gibi ciddi vasküler girişimler de gerekebilmektedir.

🔖

Cite This Article

HAMİDİ, N., BAĞCI, U., SÜER, E., GÖKCE, M. İ., TÜRKÖLMEZ, K., BEDÜK, Y., BALTACI, S. (2016). Additional Surgical Procedures During Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients with Nonseminomatous Testicular Tumor. Üroonkoloji Bülteni, Cilt: 15 - Sayı: 2, 44–47. https://ajindex.com/articles/334369

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer: 2015 update. EurUrol 2015;68:1054-1068.
  2. Beck SD, Foster RS. Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer. World J Urol 2006;24:267-272.
  3. Cary C, Masterson TA, Bihrle R, et al. Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications. Urol Oncol 2015;33:15-21.
  4. Baniel J, Foster RS, Rowland RG, et al. Complications of post- chemotherapy retroperitoneal lymoh node dissection. J Urol 1995;153:976-980.
  5. Mosharafa AA, Foster RS, Koch MO, et al. Complications of post- chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 2004;171:1839-1841.
  6. Heidenreich A, Pfister D, Witthuhn R, et al. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol 2009;55:217-224.
  7. Djaladat H, Nichols C, Daneshmand S. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol 2012;19:2388-2393.
  8. Jacobsen NE, Foster RS, Donohue JP. Retroperitoneal lymph node dissection in testicular cancer. Surg Oncol Clin N Am 2007;16:199-220.
  9. Winter C, Pfister D, Busch J, et al.Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group. Eur Urol 2012;61:403-409.